BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36549594)

  • 61. Increased Co-Occurrence of Pathogenic Variants in Hereditary Breast and Ovarian Cancer and Lynch Syndromes: A Consequence of Multigene Panel Genetic Testing?
    Infante M; Arranz-Ledo M; Lastra E; Abella LE; Ferreira R; Orozco M; Hernández L; Martínez N; Durán M
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232793
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparing Outcomes of Genetic Counseling Options in Breast and Ovarian Cancer: An Integrative Review
.
    Fournier DM; Bazzell AF; Dains JE
    Oncol Nurs Forum; 2018 Jan; 45(1):96-105. PubMed ID: 29251290
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evaluation of the need for routine clinical testing of PALB2 c.1592delT mutation in BRCA negative Northern Finnish breast cancer families.
    Haanpää M; Pylkäs K; Moilanen JS; Winqvist R
    BMC Med Genet; 2013 Aug; 14():82. PubMed ID: 23941127
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Risk information exposure and direct-to-consumer genetic testing for BRCA mutations among women with a personal or family history of breast or ovarian cancer.
    Gray SW; O'Grady C; Karp L; Smith D; Schwartz JS; Hornik RC; Armstrong K
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1303-11. PubMed ID: 19318436
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cancer surveillance behaviors in women presenting for clinical BRCA genetic susceptibility testing.
    Loescher LJ; Lim KH; Leitner O; Ray J; D'Souza J; Armstrong CM
    Oncol Nurs Forum; 2009 Mar; 36(2):E57-67. PubMed ID: 19273395
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Multigene Panel Testing Detects Equal Rates of Pathogenic BRCA1/2 Mutations and has a Higher Diagnostic Yield Compared to Limited BRCA1/2 Analysis Alone in Patients at Risk for Hereditary Breast Cancer.
    Kapoor NS; Curcio LD; Blakemore CA; Bremner AK; McFarland RE; West JG; Banks KC
    Ann Surg Oncol; 2015 Oct; 22(10):3282-8. PubMed ID: 26219241
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Familial breast cancer genetic testing in the West of Ireland.
    McVeigh TP; Irwin R; Cody N; Miller N; McDevitt T; Sweeney KJ; Green A; Kerin MJ
    Ir J Med Sci; 2014 Jun; 183(2):199-206. PubMed ID: 23884708
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.
    Franceschini G; Di Leone A; Terribile D; Sanchez MA; Masetti R
    Ann Ital Chir; 2019; 90():1-2. PubMed ID: 30872561
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Medical mistrust influences black women's level of engagement in BRCA 1/2 genetic counseling and testing.
    Sheppard VB; Mays D; LaVeist T; Tercyak KP
    J Natl Med Assoc; 2013; 105(1):17-22. PubMed ID: 23862292
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Patient-Centered Care in Breast Cancer Genetic Clinics.
    Brédart A; Anota A; Dick J; Kuboth V; Lareyre O; De Pauw A; Cano A; Stoppa-Lyonnet D; Schmutzler R; Dolbeault S; Kop JL
    Int J Environ Res Public Health; 2018 Feb; 15(2):. PubMed ID: 29439543
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Genetic screening results of individuals with high risk BRCA-related breast/ovarian cancer in Trakya region of Turkey.
    Demir S; Tozkir H; Gurkan H; Atli EI; Yalcintepe S; Atli E; Sezer YA; Eker D; Tuncbilek N; Tastekin E; Ozen Y; Cicin I
    J BUON; 2020; 25(3):1337-1347. PubMed ID: 32862574
    [TBL] [Abstract][Full Text] [Related]  

  • 72. More breast cancer patients prefer BRCA-mutation testing without prior face-to-face genetic counseling.
    Sie AS; van Zelst-Stams WA; Spruijt L; Mensenkamp AR; Ligtenberg MJ; Brunner HG; Prins JB; Hoogerbrugge N
    Fam Cancer; 2014 Jun; 13(2):143-51. PubMed ID: 24068317
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Hereditary breast and ovarian cancer: new genes in confined pathways.
    Nielsen FC; van Overeem Hansen T; Sørensen CS
    Nat Rev Cancer; 2016 Sep; 16(9):599-612. PubMed ID: 27515922
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
    ; Owens DK; Davidson KW; Krist AH; Barry MJ; Cabana M; Caughey AB; Doubeni CA; Epling JW; Kubik M; Landefeld CS; Mangione CM; Pbert L; Silverstein M; Simon MA; Tseng CW; Wong JB
    JAMA; 2019 Aug; 322(7):652-665. PubMed ID: 31429903
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The impact of a cascade testing video on recipients' knowledge, cognitive message processing, and affective reactions: A formative evaluation.
    Aeilts AM; Carpenter KM; Hovick SR; Byrne L; Shoben AB; Senter L
    J Genet Couns; 2021 Jun; 30(3):656-664. PubMed ID: 33142025
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Modeling the dyadic effects of parenting, stress, and coping on parent-child communication in families tested for hereditary breast-ovarian cancer risk.
    Hamilton JG; Mays D; DeMarco T; Tercyak KP
    Fam Cancer; 2016 Oct; 15(4):513-22. PubMed ID: 26848859
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The Genetic Education for Men (GEM) Trial: Development of Web-Based Education for Untested Men in BRCA1/2-Positive Families.
    Peshkin BN; Ladd MK; Isaacs C; Segal H; Jacobs A; Taylor KL; Graves KD; O'Neill SC; Schwartz MD
    J Cancer Educ; 2021 Feb; 36(1):72-84. PubMed ID: 31402434
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Development and pilot testing of a leaflet informing women with breast cancer about genomic testing for polygenic risk.
    Kaur R; Meiser B; Yanes T; Young MA; Barlow-Stewart K; Roscioli T; Smith S; James PA
    Fam Cancer; 2019 Apr; 18(2):147-152. PubMed ID: 30251170
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Racial and Ethnic Differences in BRCA1/2 and Multigene Panel Testing Among Young Breast Cancer Patients.
    Jones T; Trivedi MS; Jiang X; Silverman T; Underhill M; Chung WK; Kukafka R; Crew KD
    J Cancer Educ; 2021 Jun; 36(3):463-469. PubMed ID: 31802423
    [TBL] [Abstract][Full Text] [Related]  

  • 80. "You Always Have It in the Back of Your Mind"-Feelings, Coping, and Support Needs of Women with Pathogenic Variants in Moderate-Risk Genes for Hereditary Breast Cancer Attending Genetic Counseling in Germany: A Qualitative Interview Study.
    Stracke C; Lemmen C; Rhiem K; Schmutzler R; Kautz-Freimuth S; Stock S
    Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35329227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.